New marburg vaccine shows promise in early human trial
⭐️ VACCINE ⭐️
Completed
This early-stage trial tested a new vaccine called PHV01 against Marburg virus, a rare but severe disease. 36 healthy adults received either the vaccine or a placebo to check safety and immune response. The study aims to find a safe dose and see if the vaccine triggers antibodies…
Phase: PHASE1 • Sponsor: Public Health Vaccines LLC • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 13:33 UTC